 |
trafermin in combination with plasma and platelet rich plasma |
|---|---|
| Trade Name | Fiblast |
| Orphan Indication | Complex 4 mitochondrial respiratory chain deficiency |
| USA Market Approval | USA |
| USA Designation Date | |
| Sponsor | HCell, Inc. 314 East Highland Mall Boulevard, Suite 406 Austin, Texas, 78752 |
